Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

'Every week counts' as Austria, Greece, Denmark seek quick EU OK for AstraZeneca vaccine -Kurz

Mon, 18th Jan 2021 11:07

VIENNA, Jan 18 (Reuters) - Austria, Greece and Denmark will
jointly pressure the European Medicines Agency to approve
AstraZeneca's COVID-19 vaccine as quickly as possible,
Austrian Chancellor Sebastian Kurz said on Monday, adding:
"Every week counts."

Kurz was speaking before a European leaders' virtual summit
on Thursday, and a day after he said Austria's lockdown was
being extended until at least Feb. 7 as it tries to contain
highly infectious new variants.

EMA, the EU drugs regulator, said last week it would review
the vaccine developed by AstraZeneca and Britain's Oxford
University this month under an accelerated timeline.

"Every week counts," Kurz told a news conference after a
video call with various countries on dealing with the virus. "We
expect that work be done day and night, that a decision be
reached unbureaucratically and that Europe not fall behind.

"What is now needed is - based on all scientific facts, of
course - an immediate and quick decision, because AstraZeneca
can deliver up to two million doses in the first quarter for
Austria alone, and that of course makes an enormous difference
to our success in vaccinating the population."

Austria has a population of just under nine million people.

Kurz also said part of the already-approved vaccine doses
being supplied by Pfizer would arrive late, after Pfizer said it
was temporarily reducing deliveries to Europe.

"Yes, there will now have to be a small adjustment here or
there because it currently seems as though we will receive 20%
less, which will then be caught up in February at the latest,"
Kurz said.
(Reporting by Francois Murphy; Editing by Nick Macfie)

Related Shares

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.